MedPath

Seton or glue for transfinteric anal fistulas? Prospective randomised trial - ND

Conditions
transfinteric anal fistulas
MedDRA version: 9.1Level: SOCClassification code 10042613
Registration Number
EUCTR2009-013027-31-IT
Lead Sponsor
AZIENDA OSPEDALIERA OSPEDALE POLICLINICO CONSORZIALE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

patients with medium or high trans-sphincteric fistulas. Any sex and age
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

neoplasm, HIV, diabetes, anal fissures, anal abscesses, anti-coagulant treatments, immunosuppression, complex fistulas, Crohn’s disease, pregnancy, , any allergic reaction to the bioglue components.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath